DK1019374T3 - Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde - Google Patents

Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde

Info

Publication number
DK1019374T3
DK1019374T3 DK97924337T DK97924337T DK1019374T3 DK 1019374 T3 DK1019374 T3 DK 1019374T3 DK 97924337 T DK97924337 T DK 97924337T DK 97924337 T DK97924337 T DK 97924337T DK 1019374 T3 DK1019374 T3 DK 1019374T3
Authority
DK
Denmark
Prior art keywords
polymorphic
manufacturing process
donepezil hydrochloride
donepezil
hydrochloride
Prior art date
Application number
DK97924337T
Other languages
Danish (da)
English (en)
Inventor
Akio Imai
Hideaki Watanabe
Takashi Kajima
Yasushi Ishihama
Akiyo Ohtsuka
Tomohide Tanaka
Yukio Narabu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1996/003881 external-priority patent/WO1997046526A1/fr
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DK1019374T3 publication Critical patent/DK1019374T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97924337T 1996-06-07 1997-06-06 Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde DK1019374T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14629396 1996-06-07
PCT/JP1996/003881 WO1997046526A1 (fr) 1996-06-07 1996-12-27 Polymorphes stables d'hydrochlorure de 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methyl-piperidine), dit hydrochlorure de donepezil et procede pour leur production
US08/774,802 US6140321A (en) 1996-06-07 1996-12-30 Polymorphs of donepezil hydrochloride and process for production
PCT/JP1997/001932 WO1997046527A1 (fr) 1996-06-07 1997-06-06 Polymorphes de chlorhydrate de donepezil, et leur procede de production

Publications (1)

Publication Number Publication Date
DK1019374T3 true DK1019374T3 (da) 2003-04-07

Family

ID=27307991

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97924337T DK1019374T3 (da) 1996-06-07 1997-06-06 Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde

Country Status (12)

Country Link
EP (2) EP1019374B1 (fr)
AU (1) AU731282B2 (fr)
CA (1) CA2252806C (fr)
DK (1) DK1019374T3 (fr)
ES (1) ES2188946T3 (fr)
HK (1) HK1020952A1 (fr)
NO (1) NO321267B1 (fr)
NZ (1) NZ333197A (fr)
RU (1) RU2190603C2 (fr)
SI (1) SI9720038B (fr)
SK (1) SK285312B6 (fr)
WO (1) WO1997046527A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241358T1 (de) 1997-03-03 2003-06-15 Eisai Co Ltd Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
ATE260896T1 (de) 1997-12-05 2004-03-15 Eisai Co Ltd Donepezil polykristalle und verfharen zu ihrer herstellung
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
PL346242A1 (en) * 1998-06-16 2002-01-28 Lilly Co Eli Methods for increasing levels of acetylcholine
TR200003704T2 (tr) 1998-06-16 2001-06-21 Eli Lilly And Company Asetilkolin düzeylerini arttırma
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
PT1311272E (pt) 2000-03-03 2007-02-28 Eisai R&D Man Co Ltd Novos métodos utilizando inibidores de colinesterase
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
IL150509A (en) 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
AU2003287433A1 (en) * 2002-11-01 2004-06-07 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
US20050288330A1 (en) * 2004-06-29 2005-12-29 Avinash Naidu Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
WO2004092137A1 (fr) * 2003-04-16 2004-10-28 Hetero Drugs Limited Nouvelles formes cristallines de chlorhydrate de donepezil
EP1771416A1 (fr) * 2004-07-28 2007-04-11 USV Limited Nouveau polymorphe de (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochlorure (hydrochlorure de donepezil) et son procede de production
WO2006015338A2 (fr) * 2004-07-30 2006-02-09 Dr. Reddy's Laboratories Ltd. Forme cristalline de chlorhydrate de donepezil
RS51271B (sr) * 2004-10-19 2010-12-31 Krka Tovarna Zdravil D.D. Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
EP1858847A1 (fr) * 2005-02-28 2007-11-28 Ranbaxy Laboratories Limited Chlorhydrate de donepezil de formule i stable et son procede de preparation et d'utilisation dans des compositions pharmaceutiques
WO2006097341A1 (fr) * 2005-03-17 2006-09-21 Synthon B.V. Procede de preparation du monohydrate d'hydrochlorure de donepezil cristallin
WO2006111983A2 (fr) * 2005-04-21 2006-10-26 Jubilant Organosys Limited Nouvelle forme polymorphe de chlorhydrate de (l-benzyl-4-[(5,6-dimethoxy-l- indanone)-2-yl]methyl piperidine et procede permettant de preparer celle-ci
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
SI2032521T1 (sl) 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
US8247563B2 (en) 2006-12-11 2012-08-21 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
CN102603612A (zh) * 2007-09-28 2012-07-25 天津和美生物技术有限公司 多奈哌齐盐的多晶型物及其制备和应用
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
DE102010010998A1 (de) 2010-03-10 2011-09-15 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I
WO2011151359A1 (fr) 2010-06-02 2011-12-08 Noscira, S.A. Traitement combiné comprenant un inhibiteur de la cholinestérase et un dérivé de thiadiazolidinedione
EP2502620A1 (fr) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Composition pharmaceutique solide comportant du donépézil
CN110393440B (zh) * 2019-06-28 2021-08-13 顾美红 一种即热式烧水机

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
SI9720038A (sl) 1999-06-30
NO321267B1 (no) 2006-04-10
NO985721L (no) 1999-01-28
SI9720038B (sl) 2010-06-30
NO985721D0 (no) 1998-12-07
SK167698A3 (en) 1999-06-11
EP1211243B1 (fr) 2009-10-14
SK285312B6 (sk) 2006-10-05
EP1211243A1 (fr) 2002-06-05
HK1020952A1 (en) 2000-05-26
WO1997046527A1 (fr) 1997-12-11
RU2190603C2 (ru) 2002-10-10
ES2188946T3 (es) 2003-07-01
EP1019374B1 (fr) 2003-01-02
AU731282B2 (en) 2001-03-29
CA2252806A1 (fr) 1997-12-11
NZ333197A (en) 2001-03-30
CA2252806C (fr) 2005-11-22
AU2979297A (en) 1998-01-05
EP1019374A1 (fr) 2000-07-19

Similar Documents

Publication Publication Date Title
DK1019374T3 (da) Polymorfe og Donepezil-hydrochlorid og fremstillingsfremgangsmåde
NO970762L (no) Brönnstrengskjötlokalisator og fremgangsmåte derved
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
NO990122L (no) Nedihullverkt°y og fremgangsmÕte
DE69841064D1 (de) Widerstand und Herstellungsverfahren dafür
NO984373L (no) FremgangsmÕte og anordning hvor kveil-i-kveil-r°r benyttes
NO20022086L (no) Antidiabetisk formulering og fremgangsmåte
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
DE69808499D1 (de) Widerstand und herstellungsverfahren
NO20002584D0 (no) Brønnreferanseapparat og fremgangsmÕte
DE19781945T1 (de) Biegeverfahren und Biegevorrichtung
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
DE69522846D1 (de) Verbesserte Speicheranordnung und Herstellungsverfahren
NO984861D0 (no) Piperidiner og pyrrolidiner
KR960009144A (ko) 리드프레임과 그 제조방법
DE69713155D1 (de) Halbleiteranordnung und herstellungsverfahren
DK0891938T3 (da) Maskine og fremgangsmåde til stabling
DE69805736D1 (de) Umformverfahren und Umformwerkzeug
NO985806D0 (no) Kitinasematerialer og fremgangsmÕter
NO942643D0 (no) Demodulator og fremgangsmåte derved
DE59709312D1 (de) Rahmen
NO970489D0 (no) Brönnperforeringsisolasjonsapparat og metode
DK1078458T3 (da) Timingindretning og timingfremgangsmåde
DE69737986D1 (de) Epimorphin antagonist und herstellungsverfahren dafür
NO971414D0 (no) Identifikasjonsmetode og identifikasjonsapparat